Although endogenous NIS is physiologically and functionally expressed in several normal tissues, so far only 2 human cancers - some thyroid cancers, and around 80% of breast cancers including ductal carcinomas - have been shown to express endogenous NIS functionally, making them amenable to radiotherapy [22]. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.